Search Results - ella+evron

1 Results Sort By:
Aberrantly Methylated Genes as Markers of Breast Malignancy in Ductal Fluids
C03729: Detection of Aberrantly Methylated Genes in Human Samples as Markers of MalignancyTechnical Details: Inventors have identified novel genes that may be aberrantly methylated in cancer cells. A method for quantification and diagnosing such methylation has also been developed called quantitative multiplex-methylation specific PCR (QM-MSP).Advantages:...
Published: 10/3/2024   |   Inventor(s): Nicoletta Sacchi, Ella Evron, Mary jo Fackler, Nancy Davidson, William Dooley, Saraswati Sukumar
Keywords(s): Biomarker, Breast Cancer, Cancers, Clinical Diagnostics, Diagnostic Biomarker, Disease Indication, In Vitro Diagnostics, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology > Breast Cancer, Clinical and Disease Specializations > Women's Health, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > Diagnostic Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Oncology
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum